Is Baxter International Inc. (BAX) a Buy, Sell, or Hold?
NYSE : BAX
Baxter International Inc.
$22.61 USD
-$0.74 (-3.17%)
- Volume
- 4.51M
- Average Volume
- 7.1M
- Market Capitalization
- $11.68B
- P/E Ratio
- -10.77
- Dividend Yield
- 0.88%
- Price Target
- $20.00
- Year High
- $29.35
- Year Low
- $15.73
- Day High
- —
- Day Low
- —
- Payout Ratio
- -$0.24
- Current Ratio
- $1.85
Insider Activity Summary (Last 12 Months)
Insiders Buying
29
Insiders Selling
17
Amount of Insider Selling
$103.4K
BAX Insider Buying/Selling by Quarter
BAX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Wilkes David S. | director | 2026-05-05 | A-Award | 0 | 2026-05-07 |
| Wendell Amy McBride | director | 2026-05-05 | A-Award | 0 | 2026-05-07 |
| SCHLICHTING NANCY M | director | 2026-05-05 | A-Award | 0 | 2026-05-07 |
| MORRISON PATRICIA | director | 2026-05-05 | A-Award | 0 | 2026-05-07 |
| Shafer David Brent | director, other: Chair of the Board | 2026-05-05 | A-Award | 0 | 2026-05-07 |
| McDonnell Michael R. | director | 2026-05-05 | A-Award | 0 | 2026-05-07 |
| Craig Jeffrey A | director | 2026-05-05 | A-Award | 0 | 2026-05-07 |
| Ampofo William A. II | director | 2026-05-05 | A-Award | 0 | 2026-05-07 |
| Foster Julie | officer: President, Front Line Care | 2026-04-01 | 0 | 2026-04-09 | |
| Foster Julie | officer: President, Front Line Care | 2026-04-01 | 20.37 | 2026-04-09 | |
| Wallace Steven P. | officer: President, Adv. Surgery | 2026-04-01 | 0 | 2026-04-09 | |
| Wallace Steven P. | officer: President, Adv. Surgery | 2026-04-01 | 74.47 | 2026-04-09 | |
| Wallace Steven P. | officer: President, Adv. Surgery | 2026-04-01 | 39.06 | 2026-04-09 | |
| Wallace Steven P. | officer: President, Adv. Surgery | 2026-04-01 | 35.44 | 2026-04-09 | |
| Wallace Steven P. | officer: President, Adv. Surgery | 2026-04-01 | 20.37 | 2026-04-09 | |
| Teaff James | officer: President, CCS | 2026-04-01 | 0 | 2026-04-09 | |
| Teaff James | officer: President, CCS | 2026-04-01 | 66.31 | 2026-04-09 | |
| Teaff James | officer: President, CCS | 2026-04-01 | 50.77 | 2026-04-09 | |
| Teaff James | officer: President, CCS | 2026-04-01 | 74.73 | 2026-04-09 | |
| Teaff James | officer: President, CCS | 2026-04-01 | 75.75 | 2026-04-09 | |
| Teaff James | officer: President, CCS | 2026-04-01 | 77.15 | 2026-04-09 | |
| Teaff James | officer: President, CCS | 2026-04-01 | 85.23 | 2026-04-09 | |
| Teaff James | officer: President, CCS | 2026-04-01 | 39.06 | 2026-04-09 | |
| Teaff James | officer: President, CCS | 2026-04-01 | 20.37 | 2026-04-09 | |
| Zielinski Anita A | officer: SVP, CAO and Controller | 2026-03-06 | F-InKind | 17.69 | 2026-03-10 |
| Soriano Maria Cecilia | officer: Group Pres., ITT & Pharma. | 2026-03-06 | F-InKind | 17.69 | 2026-03-10 |
| Rosenbloom David S. | officer: EVP and General Counsel | 2026-03-06 | F-InKind | 17.69 | 2026-03-10 |
| Rasul Reazur | officer: EVP,Group Pres,Healthcare | 2026-03-06 | F-InKind | 17.69 | 2026-03-10 |
| Grade Joel T. | officer: EVP and CFO | 2026-03-06 | F-InKind | 17.69 | 2026-03-10 |
| Hider Andrew P. | director, officer: President and CEO | 2026-02-27 | A-Award | 0 | 2026-03-03 |
| Hider Andrew P. | director, officer: President and CEO | 2026-02-27 | A-Award | 20.37 | 2026-03-03 |
| Carlisle Cynthia | officer: Executive Vice President, CHRO | 2026-02-27 | A-Award | 20.37 | 2026-03-03 |
| Carlisle Cynthia | officer: Executive Vice President, CHRO | 2026-02-27 | A-Award | 0 | 2026-03-03 |
| Carlisle Cynthia | officer: Executive Vice President, CHRO | 2026-02-27 | A-Award | 0 | 2026-03-03 |
| Rasul Reazur | officer: EVP,Group Pres,Healthcare | 2026-03-02 | F-InKind | 19.69 | 2026-03-03 |
| Soriano Maria Cecilia | officer: Group Pres., ITT & Pharma. | 2026-02-27 | A-Award | 0 | 2026-03-03 |
| Soriano Maria Cecilia | officer: Group Pres., ITT & Pharma. | 2026-03-02 | F-InKind | 19.69 | 2026-03-03 |
| Soriano Maria Cecilia | officer: Group Pres., ITT & Pharma. | 2026-02-27 | A-Award | 20.37 | 2026-03-03 |
| Rosenbloom David S. | officer: EVP and General Counsel | 2026-02-27 | A-Award | 0 | 2026-03-03 |
| Rosenbloom David S. | officer: EVP and General Counsel | 2026-03-02 | F-InKind | 19.69 | 2026-03-03 |
| Rosenbloom David S. | officer: EVP and General Counsel | 2026-02-27 | A-Award | 20.37 | 2026-03-03 |
| Grade Joel T. | officer: EVP and CFO | 2026-02-27 | A-Award | 0 | 2026-03-03 |
| Grade Joel T. | officer: EVP and CFO | 2026-02-27 | A-Award | 20.37 | 2026-03-03 |
| Zielinski Anita A | officer: SVP, CAO and Controller | 2026-02-27 | A-Award | 0 | 2026-03-03 |
| Carlisle Cynthia | officer: Executive Vice President, CHRO | 2026-02-23 | 0 | 2026-03-03 | |
| McDonnell Michael R. | director | 2026-02-13 | A-Award | 0 | 2026-02-18 |
| McDonnell Michael R. | director | 2026-02-13 | 0 | 2026-02-18 | |
| Soriano Maria Cecilia | officer: Group Pres., ITT & Pharma. | 2026-02-09 | A-Award | 0 | 2026-02-11 |
| Soriano Maria Cecilia | officer: Group Pres., ITT & Pharma. | 2026-02-09 | F-InKind | 21.73 | 2026-02-11 |
| Rosenbloom David S. | officer: EVP and General Counsel | 2026-02-09 | A-Award | 0 | 2026-02-11 |
| Rosenbloom David S. | officer: EVP and General Counsel | 2026-02-09 | F-InKind | 21.73 | 2026-02-11 |
| Rasul Reazur | officer: EVP,Group Pres,Healthcare | 2026-02-09 | A-Award | 0 | 2026-02-11 |
| Rasul Reazur | officer: EVP,Group Pres,Healthcare | 2026-02-09 | F-InKind | 21.73 | 2026-02-11 |
| Grade Joel T. | officer: EVP and CFO | 2026-02-09 | A-Award | 0 | 2026-02-11 |
| Grade Joel T. | officer: EVP and CFO | 2026-02-09 | F-InKind | 21.73 | 2026-02-11 |
| Mason Jeanne K | officer: EVP, Chief HR Officer | 2025-12-12 | F-InKind | 19.15 | 2025-12-16 |
| Soriano Maria Cecilia | officer: Group Pres., ITT & Pharma. | 2025-12-01 | 0 | 2025-12-10 | |
| Soriano Maria Cecilia | officer: Group Pres., ITT & Pharma. | 2025-12-01 | 35.44 | 2025-12-10 | |
| Soriano Maria Cecilia | officer: Group Pres., ITT & Pharma. | 2025-12-01 | 39.06 | 2025-12-10 | |
| Grade Joel T. | officer: EVP and CFO | 2025-12-01 | F-InKind | 19.08 | 2025-12-03 |
| Sonig Alok | officer: EVP,Group President,Pharma | 2025-09-02 | F-InKind | 24.17 | 2025-09-04 |
| Hider Andrew P. | director, officer: President and CEO | 2025-09-02 | A-Award | 24.17 | 2025-09-04 |
| Hider Andrew P. | director, officer: President and CEO | 2025-09-02 | A-Award | 0 | 2025-09-04 |
| Hider Andrew P. | director, officer: President and CEO | 2025-09-02 | A-Award | 0 | 2025-09-04 |
| Grade Joel T. | officer: EVP and CFO | 2025-09-02 | A-Award | 0 | 2025-09-04 |
| Borzi James W | officer: EVP,Chief Supply Chain Officer | 2025-09-02 | F-InKind | 24.17 | 2025-09-04 |
| Hider Andrew P. | director, officer: President and CEO | 2025-08-19 | 0 | 2025-08-25 | |
| Shafer David Brent | director, other: Chair of the Board | 2025-08-19 | F-InKind | 24.33 | 2025-08-21 |
| Rosenbloom David S. | officer: EVP and General Counsel | 2025-06-02 | F-InKind | 29.55 | 2025-06-04 |
| Wilkes David S. | director | 2025-05-06 | A-Award | 0 | 2025-05-08 |
| Wendell Amy McBride | director | 2025-05-06 | A-Award | 0 | 2025-05-08 |
| Smith Cathy R | director | 2025-05-06 | A-Award | 0 | 2025-05-08 |
| SCHLICHTING NANCY M | director | 2025-05-06 | A-Award | 0 | 2025-05-08 |
| RUSCKOWSKI STEPHEN H | director | 2025-05-06 | A-Award | 0 | 2025-05-08 |
| Oesterle Stephen N. | director | 2025-05-06 | A-Award | 0 | 2025-05-08 |
| MORRISON PATRICIA | director | 2025-05-06 | A-Award | 0 | 2025-05-08 |
| Ampofo William A. II | director | 2025-05-06 | A-Award | 0 | 2025-05-08 |
| Craig Jeffrey A | director | 2025-05-06 | A-Award | 0 | 2025-05-08 |
| Zielinski Anita A | officer: SVP, CAO and Controller | 2025-03-06 | A-Award | 0 | 2025-03-10 |
| Sonig Alok | officer: EVP,Group President,Pharma | 2025-03-06 | A-Award | 0 | 2025-03-10 |
| Sonig Alok | officer: EVP,Group President,Pharma | 2025-03-06 | F-InKind | 35.44 | 2025-03-10 |
| Sonig Alok | officer: EVP,Group President,Pharma | 2025-03-06 | A-Award | 35.44 | 2025-03-10 |
| Rosenbloom David S. | officer: EVP and General Counsel | 2025-03-06 | A-Award | 0 | 2025-03-10 |
| Rosenbloom David S. | officer: EVP and General Counsel | 2025-03-06 | F-InKind | 35.44 | 2025-03-10 |
| Rosenbloom David S. | officer: EVP and General Counsel | 2025-03-06 | A-Award | 35.44 | 2025-03-10 |
| Rasul Reazur | officer: EVP,Group Pres,Healthcare | 2025-03-06 | A-Award | 0 | 2025-03-10 |
| Rasul Reazur | officer: EVP,Group Pres,Healthcare | 2025-03-06 | F-InKind | 35.44 | 2025-03-10 |
| Rasul Reazur | officer: EVP,Group Pres,Healthcare | 2025-03-06 | A-Award | 35.44 | 2025-03-10 |
| Mason Jeanne K | officer: EVP, Chief HR Officer | 2025-03-06 | A-Award | 0 | 2025-03-10 |
| Mason Jeanne K | officer: EVP, Chief HR Officer | 2025-03-06 | F-InKind | 35.44 | 2025-03-10 |
| Mason Jeanne K | officer: EVP, Chief HR Officer | 2025-03-06 | A-Award | 35.44 | 2025-03-10 |
| Knight Heather | officer: EVP, Chief Operating Officer | 2025-03-06 | A-Award | 0 | 2025-03-10 |
| Knight Heather | officer: EVP, Chief Operating Officer | 2025-03-06 | F-InKind | 35.44 | 2025-03-10 |
| Knight Heather | officer: EVP, Chief Operating Officer | 2025-03-06 | A-Award | 35.44 | 2025-03-10 |
| Grade Joel T. | officer: EVP and CFO | 2025-03-06 | A-Award | 0 | 2025-03-10 |
| Grade Joel T. | officer: EVP and CFO | 2025-03-06 | A-Award | 35.44 | 2025-03-10 |
| Grade Joel T. | officer: EVP and CFO | 2025-03-06 | F-InKind | 35.44 | 2025-03-10 |
| Borzi James W | officer: EVP,Chief Supply Chain Officer | 2025-03-06 | A-Award | 0 | 2025-03-10 |
| Borzi James W | officer: EVP,Chief Supply Chain Officer | 2025-03-06 | F-InKind | 35.44 | 2025-03-10 |
| Borzi James W | officer: EVP,Chief Supply Chain Officer | 2025-03-06 | A-Award | 35.44 | 2025-03-10 |